This contract expires in 208 days (Dec 31, 2026).
THE EMMES COMPANY, LLC - VRC 316/317/320/603 CLINICAL MONITORING: POP: 5/1/19 - 3/28/21
Key Details
Description
VRC 316/317/320/603 CLINICAL MONITORING: POP: 5/1/19 - 3/28/21
Context & Analysis
On Jan 21, 2026, Department of Health and Human Services obligated $174,115.89 to THE EMMES COMPANY, LLC for vrc 316/317/320/603 clinical monitoring: pop: 5/1/19 - 3/28/21. The award is classified under NAICS 541711 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY and issued as a cost plus fixed fee contract. Competition extent: full and open competition after exclusion of sources with 1 offer received. Performance is located in ROCKVILLE, MD. The contract is scheduled through Dec 31, 2026 — approximately 7 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541711 — related awards are listed below.
Contractor Information
Similar Awards
CERUS - DEVELOPMENT AND IMPLEMENTATION OF PATHOGEN REDUCTION TECHNOLOGY (PRT). IGF::OT::IGF
CERUS CORPORATION
$185.5M
THE MEDICINE COMPANY - ADVANCE THE DEVELOPMENT OF A PORTFOLIO OF ANTI-INFECTIVE PROGRAMS. IGF::OT::IGF
MEDICINES COMPANY, THE
$98.1M
IGF::OT::IGF
JANSSEN VACCINES & PREVENTION B.V.
$48.9M
IGF::OT::IGF - DNAE / PATHOGEN IDENTIFICATION FROM SPECIMEN, VIA CAPTURE, EXTRACTION AND SEQUENCING (PISCES)
DNAE GROUP HOLDINGS LIMITED
$43.4M
AUTOGRAFT-SPARING PRODUCTS FOR DEFINITIVE CARE OF BURN INJURIES
AVITA MEDICAL AMERICAS, LLC
$40.8M
Stay Updated
Get notified about new opportunities matching your interests.